Can Increased Body Mass Index Prevent Adequate Ultrasound Examination for Trisomy 21 Risk Assessment?
1 other identifier
observational
200
1 country
1
Brief Summary
Determine Cutoff BMI at which transabdominal sonography (TAS) is not satisfactory for aneuploidy risk assessment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2015
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 2, 2015
CompletedFirst Posted
Study publicly available on registry
May 14, 2015
CompletedStudy Start
First participant enrolled
June 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2016
CompletedJanuary 20, 2016
January 1, 2016
6 months
May 2, 2015
January 16, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cutoff body mass index for the use of transvaginal ultrasound for aneuploidy risk assessment.
30 minutes
Secondary Outcomes (3)
The time of the study. (time needed for satisfactory ultrasound risk assessment in minutes)
30 minutes
The tolerance of the woman for trans-vaginal ultrasound.
30 minutes
The harmful effect to the patient
12 hours
Study Arms (2)
obese pregnant women
With the use of trans-abdominal ultrasound, the following measurements will be recorded: * Fetal nuchal translucency thickness. * Nasal bone. * Fetal facio-maxillary angle. * The flow across the tricuspid valve as normal or regurgitated. * A-wave in the ductus venosus as normal or reversed.
lean pregnant women
With the use of trans-abdominal ultrasound, the following measurements will be recorded: * Fetal nuchal translucency thickness. * Nasal bone. * Fetal facio-maxillary angle. * The flow across the tricuspid valve as normal or regurgitated. * A-wave in the ductus venosus as normal or reversed.
Interventions
trans abdominal or trans vaginal ultrasound to detect some of the soft markers of trisomy screening
Eligibility Criteria
Inclusion criteria will consist of women who have a live, intrauterine, singleton pregnancy between 11- 14 weeks gestation.
You may qualify if:
- women who have a live, intrauterine, singleton pregnancy between 11- 14 weeks gestation.
You may not qualify if:
- multiple gestation.
- fetal size outside of nuchal translucency screening age (crown-rump length (CRL) outside of 46-71 mm).
- presence of a cystic hygroma.
- fetal demise.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
antenatal clinic of Armed Forces Hospital, Southern Region
Khamis Mushait, 'Asir Region, 101, Saudi Arabia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
ahmed altraigey
Benha University
- PRINCIPAL INVESTIGATOR
haytham atia
Zagazig University
- PRINCIPAL INVESTIGATOR
nuzhat amer
Armed Forces Hospitals, Southern Region, Saudi Arabia
- STUDY CHAIR
Mohamed Kolkailah
Armed Forces Hospitals, Southern Region, Saudi Arabia
- PRINCIPAL INVESTIGATOR
mohammed ellaithy
Ain Shams University
- PRINCIPAL INVESTIGATOR
magdy eldumairy
Armed Forces Hospitals, Southern Region, Saudi Arabia
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer
Study Record Dates
First Submitted
May 2, 2015
First Posted
May 14, 2015
Study Start
June 1, 2015
Primary Completion
December 1, 2015
Study Completion
January 1, 2016
Last Updated
January 20, 2016
Record last verified: 2016-01